Thomas Efferth
Thomas Efferth
Professor of Pharmacy (Chair)
Email verificata su uni-mainz.de
Titolo
Citata da
Citata da
Anno
The anti-malarial artesunate is also active against cancer
T Efferth, H Dunstan, A Sauerbrey, H Miyachi, CR Chitambar
International journal of oncology 18 (4), 767-773, 2001
7922001
Molecular modes of action of artesunate in tumor cell lines
T Efferth, A Sauerbrey, A Olbrich, E Gebhart, P Rauch, HO Weber, ...
Molecular pharmacology 64 (2), 382-394, 2003
5122003
From traditional Chinese medicine to rational cancer therapy
T Efferth, PCH Li, VSB Konkimalla, B Kaina
Trends in molecular medicine 13 (8), 353-361, 2007
4982007
Antimicrobial activity of clove and rosemary essential oils alone and in combination
YJ Fu, YG Zu, LY Chen, XG Shi, Z Wang, S Sun, T Efferth
Phytotherapy research 21 (10), 989-994, 2007
4392007
Chemotherapy-induced resistance by ATP-binding cassette transporter genes
JP Gillet, T Efferth, J Remacle
Biochimica et Biophysica Acta (BBA)-Reviews on Cancer 1775 (2), 237-262, 2007
4162007
The antiviral activities of artemisinin and artesunate
T Efferth, MR Romero, DG Wolf, T Stamminger, JJG Marin, M Marschall
Clinical Infectious Diseases 47 (6), 804-811, 2008
3782008
Complex interactions between phytochemicals. The multi-target therapeutic concept of phytotherapy
T Efferth, E Koch
Current drug targets 12 (1), 122-132, 2011
3372011
Enhancement of cytotoxicity of artemisinins toward cancer cells by ferrous iron
T Efferth, A Benakis, MR Romero, M Tomicic, R Rauh, D Steinbach, ...
Free Radical Biology and Medicine 37 (7), 998-1009, 2004
3232004
Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells
T Efferth
Current drug targets 7 (4), 407-421, 2006
3212006
Molecular principles of cancer invasion and metastasis
MF Leber, T Efferth
International journal of oncology 34 (4), 881-895, 2009
2992009
Activity of drugs from traditional Chinese medicine toward sensitive and MDR1-or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells
T Efferth, M Davey, A Olbrich, G Rcker, E Gebhart, R Davey
Blood Cells, Molecules, and Diseases 28 (2), 160-168, 2002
2862002
Activities of ten essential oils towards Propionibacterium acnes and PC-3, A-549 and MCF-7 cancer cells
Y Zu, H Yu, L Liang, Y Fu, T Efferth, X Liu, N Wu
Molecules 15 (5), 3200-3210, 2010
2692010
Inhibition of angiogenesis in vivo and growth of Kaposi's sarcoma xenograft tumors by the anti-malarial artesunate
R Dell’Eva, U Pfeffer, R Ven, L Anfosso, A Forlani, A Albini, T Efferth
Biochemical pharmacology 68 (12), 2359-2366, 2004
2652004
Willmar Schwabe Award 2006: antiplasmodial and antitumor activity of artemisinin-from bench to bedside
T Efferth
Planta medica 73 (04), 299-309, 2007
2632007
Microarray-based detection of multidrug resistance in human tumor cells by expression profiling of ATP-binding cassette transporter genes
JP Gillet, T Efferth, D Steinbach, J Hamels, F De Longueville, V Bertholet, ...
Cancer research 64 (24), 8987-8993, 2004
2522004
Rapid microwave-assisted transesterification of yellow horn oil to biodiesel using a heteropolyacid solid catalyst
S Zhang, YG Zu, YJ Fu, M Luo, DY Zhang, T Efferth
Bioresource technology 101 (3), 931-936, 2010
2502010
Artesunate induces ROS-mediated apoptosis in doxorubicin-resistant T leukemia cells
T Efferth, M Giaisi, A Merling, PH Krammer, M Li-Weber
PloS one 2 (8), e693, 2007
2472007
Effect of artemisinin/artesunate as inhibitors of hepatitis B virus production in an “in vitro” replicative system
MR Romero, T Efferth, MA Serrano, B Castao, RIR Macias, O Briz, ...
Antiviral research 68 (2), 75-83, 2005
2472005
Artesunate in the treatment of metastatic uveal melanoma-first experiences
TG Berger, D Dieckmann, T Efferth, ES Schultz, JO Funk, A Baur, ...
Oncology reports 14 (6), 1599-1603, 2005
2212005
The role of p53 in cancer drug resistance and targeted chemotherapy
K Hientz, A Mohr, D Bhakta-Guha, T Efferth
Oncotarget 8 (5), 8921, 2017
2142017
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20